LAUR in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with LAUR today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Laureate Education serves students seeking undergraduate, graduate and specialized higher education through UVM and UNITEC in Mexico and UPC, UPN and CIBERTEC in Peru. Its programs emphasize preparation for professional careers, particularly in health sciences, engineering, information technology and business. Campus, online and hybrid courses serve both traditional students and working adults.
Students’ tuition supplies most revenue, with student fees and short courses contributing less. Essentially all revenue comes from private-pay sources; neither country has a material government-sponsored student-loan program. What Laureate earns depends on recruiting students, keeping them enrolled and the tuition they pay after scholarships and discounts. Students’ ability to afford their studies and the institutions’ reputations therefore matter to the business.
Government approvals restrict which programs the institutions can offer. In Mexico, recognition applies to each program at each campus, and changing either requires new recognition. In Peru, UPC and UPN must continue meeting basic quality conditions to retain their university licenses.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Laureate Education, Inc.’s results depend chiefly on private-pay enrollment, tuition affordability and local competition in Mexico and Peru, while peso and sol exchange rates affect its reported dollar results.
Afya Limited offers a comparison for Laureate Education, Inc.’s exposure to demand and affordability for professional degrees: Afya charges students for medical and health-science education in Brazil, while Laureate earns private-pay tuition at universities in Mexico and Peru with extensive healthcare programs. Watch demand for Afya’s undergraduate medical programs as a sign of appetite for healthcare degrees, rather than a direct measure of Laureate’s local markets.
Covista Inc. and Laureate Education, Inc. both earn education revenue from students pursuing healthcare careers, making Covista a comparison for healthcare-degree demand rather than a rival in the same local markets. Covista’s nursing and medical-school enrollment is the area to watch alongside Laureate’s medical-school network in Mexico and Peru.
Laureate Education, Inc. earningsThis company
Laureate Education earns tuition from students in Mexico and Peru, and this report will show whether enrollment and tuition revenue are growing together.
Read period-end enrollment alongside tuition revenue. If both rise, more students are registered and tuition income is keeping pace. If enrollment rises but tuition revenue lags, discounts, program mix or pricing may be reducing tuition earned per student. If both weaken, enrollment or students’ ability to pay is under pressure in Laureate’s two markets.
Covista Inc. earningsCVSA
Covista’s report will show demand for its nursing and medical-school programs, offering a comparison for demand at Laureate’s medical schools in Mexico and Peru.
Focus on enrollment in Covista’s nursing and medical programs. Growth would suggest sustained student demand for healthcare careers, a supportive comparison for Laureate’s health-sciences programs; a decline would point to possible cooling demand. The companies operate in different countries, so Covista’s results are not direct evidence of Laureate’s local enrollment.